Nir Sassi - 04 Aug 2021 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Issuer symbol
INDP
Transactions as of
04 Aug 2021
Net transactions value
$0
Form type
4
Filing time
06 Aug 2021, 17:00:57 UTC
Previous filing
02 Aug 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 04 Aug 2021 Common Stock 35,000 $8.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable over a period of twelve months in four equal quarterly installments and accelerate upon termination of Mr. Sassi's consulting agreement with Indaptus Therapeutics, Inc.